Digital health company Better Therapeutics has submitted its lead prescription digital therapeutic (DTx) BT-001 to the FDA, seeking approval for use by adults with type 2 diabetes (T2D).

Otsuka and Click Therapeutics’ Rejoyn has become the first prescription digital therapeutic (DTx) to be approved by the FDA for people with major depressive disorder. Rejoyn (formerly CT-152), a ...

Cold and cough are among the most common health issues that affect children. While they are usually not serious, they can cause significant discomfort and distress for both children and parents. Young ...

General Hospital VIDEO Sneak Peek for the week of March 24: Ava and Kristina cause chaos for Port Charles General Hospital VIDEO Sneak Peek for the week of March 24: Ava and Kristina cause chaos for ...